One of the fastest growing companies in the MENA region (Middle East and North Africa), based in Cairo, Eva Pharma announced the start of production of two drugs for the treatment of patients with COVID-19 - remdesivir (remdesivir) and favipiravir (favipiravir).
Recall that remdesivir is indicated for moderate to severe cases of COVID-19 for patients who require oxygen, while favipiravir is indicated for mild to moderate cases.